Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer

Clinical trial NCT03511196 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03511196
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Prostate Cancer Stage IV Prostate Cancer Advanced Prostate Cancer Adenocarcinoma of the Prostate

Start date: 2018-09-17
Primary completion: 2022-06-22
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.